Gene Therapy Deals, Collaborations, & Partnerships with Astellas' Richard Wilson

<p>Richard Wilson, Senior Vice President, Primary Focus Lead, Genetic Regulation at Astellas sat down with Cell &amp; Gene: The Podcast&apos;s Erin Harris at ARM&apos;s 2023 Meeting on the Mesa to discuss the gene therapy deal making landscape as well as Astellas&apos; recent deals and collaborations. They also discussed Astellas&apos; strategic approach since having acquired Audentes back in 2020.</p>